PlainRecalls
FDA Devices Moderate Class II Terminated

IgA Immunoturbidimetric Assay- In vitro determination of IgA and IgM in serum and plasma Catalog Number: IA3832

Reported: December 14, 2022 Initiated: November 1, 2022 #Z-0362-2023

Product Description

IgA Immunoturbidimetric Assay- In vitro determination of IgA and IgM in serum and plasma Catalog Number: IA3832

Reason for Recall

Update to the carryover avoidance technical bulletin to detail that IgA and IgM assays should not be run immediately after Fructosamine Catalogue Number FR3133 or FR4030 on the RX instruments testing order. Can lead to an elevation in Quality Control and Patient results of up to +13% for lgA and +51% for lgM respectively, which may lead to a delay in running patient samples or erroneous elevated test results

Details

Recalling Firm
Randox Laboratories Ltd.
Units Affected
20 kits US in total
Distribution
US Nationwide Distribution: CA, NC, NJ and WV,
Location
Crumlin (North), N/A

Frequently Asked Questions

What product was recalled?
IgA Immunoturbidimetric Assay- In vitro determination of IgA and IgM in serum and plasma Catalog Number: IA3832. Recalled by Randox Laboratories Ltd.. Units affected: 20 kits US in total.
Why was this product recalled?
Update to the carryover avoidance technical bulletin to detail that IgA and IgM assays should not be run immediately after Fructosamine Catalogue Number FR3133 or FR4030 on the RX instruments testing order. Can lead to an elevation in Quality Control and Patient results of up to +13% for lgA and +51% for lgM respectively, which may lead to a delay in running patient samples or erroneous elevated test results
Which agency issued this recall?
This recall was issued by the FDA Devices on December 14, 2022. Severity: Moderate. Recall number: Z-0362-2023.